Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Some ccRCC subtypes associated with CT features

Bowen L, Xiaojing L. Acad Radiol. 2018 Jul 29. doi: 10.1016/j.acra.2018.05.002

Publish date:: August 14, 2018

Key clinical point: Radiogenomic analysis may allow detection of clear cell renal cell carcinoma (ccRCC) subtypes.

Major finding: Well-defined tumor margins on CT were significantly associated with the ccRCC m1 subtype.

Study details: Retrospective analysis of the association between CT features and molecular subtype in 177 patients with ccRCC.

Disclosures: The authors did not report study funding sources or potential conflicts of interest.

Read the article.

Citation:

Bowen L, Xiaojing L. Acad Radiol. 2018 Jul 29. doi: 10.1016/j.acra.2018.05.002

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Renal Cell Carcinoma

Study shows no link between race and mortality in clear cell RCC,

Four factors may predict better survival with cabozantinib in mRCC,

Fear of recurrence highly prevalent in RCC survivors,

Risk factors for severe immune-related AEs identified,

Pembrolizumab plus axitinib continues to outshine sunitinib for advanced RCC,

All Specialties